Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

609 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Recruiting

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

NCT07036133

Conditions
Advanced Solid Tumors, Hematologic Diseases, Hematologic Malignancies, +4 more
Locations
  • TOI Clinical Research Cerritos, California, United States
  • Northwestern University - Feinberg School of Medicine Chicago, Illinois, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Gabrail Cancer Center Canton, Ohio, United States
View Trial Details
Recruiting

HEAT Trial (HER2 Antibody Therapy With Lutetium-177)

NCT06824155

Conditions
Advanced Solid Tumors, HER2 Gene Mutation
Locations
  • Nepean Hospital Kingswood, New South Wales, Australia
  • Macquarie University Hospital Macquarie Park, New South Wales, Australia
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • St Vincents Hospital, Melbourne Fitzroy, Victoria, Australia
View Trial Details
Recruiting

An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors

NCT07359066

Conditions
Advanced Solid Tumors, PARP Inhibitor
Locations
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • The Affiliated Tumor Hospital of Harbin Medical University Harbin, Heilongjiang, China
View Trial Details
Recruiting

A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

NCT06697197

Conditions
Advanced Solid Tumors
Locations
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center Irvine, California, United States
  • The Angeles Clinic and Research Institute - West Los Angeles Office Los Angeles, California, United States
  • Local Institution - 0008 Aurora, Colorado, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View all 21 locations
View Trial Details
Recruiting

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

NCT07148128

Conditions
Advanced Solid Tumors, Advanced or Metastatic KRAS-mutant Tumor, Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer, +28 more
Locations
  • NEXT Oncology Dallas Dallas, Texas, United States
  • Next Oncology, San Antonio San Antonio, Texas, United States
  • Princess Margareth Cancer Center Toronto, Ontario, Canada
  • Oxford University Hospital Headington, Oxford, United Kingdom
View Trial Details
Recruiting

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

NCT05867420

Conditions
Advanced Solid Tumors
Locations
  • Columbia University Irving Medical Center New York, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
  • Peking University Cancer Hospital Beijing, Beijing Municipality, China
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
View Trial Details

Related conditions